113 related articles for article (PubMed ID: 1867031)
1. [The use of immunoenzyme analysis and the vibriocidal antibody reaction in the serological examination of persons who have had cholera and of those in contact with them].
Mareev VI; Moskvitina EA; Gritsenko AN; Ivanova LV; Efanova EA; Nepomniashchaia NB; Dranov IIu; Boldyr' LA; Griseva LN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):34-6. PubMed ID: 1867031
[TBL] [Abstract][Full Text] [Related]
2. [The evaluation of the vibriocidal antibody test in establishing a diagnosis of cholera or Vibrio carriage].
Savel'ev VN; Efremenko VI; Gnutov IN; Kiseleva TF; Bogdanov IK; Postovoĭ PP; Latypova MS; Abolina TA; Degtiareva SN; Onatskiĭ II
Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):55-7. PubMed ID: 1301665
[TBL] [Abstract][Full Text] [Related]
3. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
5. [Utilization of serological methods in the retrospective diagnosis of cholera and in detecting vibrion carriers].
Bunin KV; Firsanov VI; Kravtsov EG; Nechaeva IP; Efimov DD
Zh Mikrobiol Epidemiol Immunobiol; 1975 Oct; (10):98-101. PubMed ID: 1210898
[TBL] [Abstract][Full Text] [Related]
6. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
[TBL] [Abstract][Full Text] [Related]
7. Serological studies in cholera infection in Calcutta (1966-67).
Deb BC; Ganguly R; Sinho R; Ghosh AK; Succar BK; Abou-Gareeb AH; Ozawa A; Shrivastava DL; Burrows W
Indian J Med Res; 1973 Feb; 61(2):169-78. PubMed ID: 4758991
[No Abstract] [Full Text] [Related]
8. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients.
Takeda T; Ramamurthy T; Chowdhury AS; Dutta D; Bhattacharya SK; Deb BC; Nair GB; Takeda Y
J Infect; 1994 Sep; 29(2):233-5. PubMed ID: 7806891
[No Abstract] [Full Text] [Related]
9. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
Harris JR; Holmberg SD; Parker RD; Kay DE; Barrett TJ; Young CR; Levine MM; Blake PA
Am J Epidemiol; 1986 Mar; 123(3):424-30. PubMed ID: 3946388
[TBL] [Abstract][Full Text] [Related]
10. [Method of preparation of erythrocytic diagnostic agents for detection of antitoxic and antibacterial antibodies in El Tor cholera].
Tsybin BP; Taran IF
Lab Delo; 1975; (3):170-2. PubMed ID: 48596
[No Abstract] [Full Text] [Related]
11. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
Yang JS; An SJ; Jang MS; Song M; Han SH
PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
[TBL] [Abstract][Full Text] [Related]
12. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
Fernandez-Miyakawa ME; Brero ML; Mateo NA
Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
[TBL] [Abstract][Full Text] [Related]
13. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1].
Bendib A; Bougoudogo F; Messast M; Rezkallah D; Hamchi L; Bellouche Y; Aidoud NS; Keddouri A; Fournier JM; Dodin A
Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
Majumdar AS; Dutta P; Dutta D; Ghose AC
Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
[TBL] [Abstract][Full Text] [Related]
16. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children.
Taylor DN; Cárdenas V; Perez J; Puga R; Svennerholm AM
Am J Trop Med Hyg; 1999 Dec; 61(6):869-73. PubMed ID: 10674661
[TBL] [Abstract][Full Text] [Related]
17. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
Khan MU; Barua DK; Begum T; Shahidullah M
Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
[TBL] [Abstract][Full Text] [Related]
18. Duration of infection-derived immunity to cholera.
Levine MM; Black RE; Clements ML; Cisneros L; Nalin DR; Young CR
J Infect Dis; 1981 Jun; 143(6):818-20. PubMed ID: 7252264
[TBL] [Abstract][Full Text] [Related]
19. [The properties of the Vibrio cholerae strains isolated in large districts in western Dagestan in 1994].
Cherepakhina IIa; Lomov IuM; Karagozova AV; Pomukhina OI; Smolikova LM; Makedonova LD; Dimitrova NI; Nekliaev VN; Balakhnova VV; Chirkova OO
Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():84-6. PubMed ID: 7771155
[TBL] [Abstract][Full Text] [Related]
20. Vibriocidal assays to determine the antibody titer of patient sera samples.
Son MS; Taylor RK
Curr Protoc Microbiol; 2011 Nov; Chapter 6():Unit6A.3. PubMed ID: 22045586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
